Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2016
Corinne M. Linardic, M.D., Ph.D.
Targeting the Hippo Pathway in Ras-driven Rhabdomyosarcoma
Read More
2016
Leonid Metelitsa, M.D., Ph.D.
Development of Salmonella-based MYCN vaccine for immunotherapy of neuroblastoma
Read More
2016
Adam Murphy, M.D.
A Prospective Validation of a Prostate Cancer Biomarker in African American Men
Read More
2016
David Tuveson, M.D., Ph.D.
Improving the treatment of pancreatic cancer patients with organoids
Read More
2016
Michael Weber, M.D.
Molecular Analysis and Therapeutic Co-Targeting of Adaptive Resistance to Therapies that Target...
Read More
2016
Mazhar Adli, Ph.D.
Epigenetic engineering to correct and aberrantly regulated locus in cancer
Read More
2016
Ash Alizadeh, M.D., Ph.D.
Direct Quantitation of Circulating Cell-Free DNA by Sequencing
Read More
2016
Michael Armstrong, M.D., Ph.D.
Genetically Engineered Mouse Models of Neuroblastoma: the Impact of Mxi1 and Mxi0...
Read More
2016
Terry Badger, Ph.D.
Psychosocial Intervention to Improve Quality of Life in Latinas with Breast Cancer...
Read More
2016
Jeffrey Clarke, M.D.
Identification of Genetic Determinates for Disparities in African American Patients with Non-Small...
Read More
2016
John Cole, M.D.
Optimizing Minority Participation in Cancer Clinical Trial through Coordinated Multidisciplinary Community Education
Read More
2016
Emily Dykhuizen, Ph.D.
The role of the bromodomains of PBRM1, a tumor suppressive subunit of...
Read More
2016
Angela Fleischman, M.D., Ph.D.
Pathogenesis of calreticulin-mutated myeloproliferative neoplasm
Read More
2016
James Ford, M.D.
Gastric Cancer Registry
Read More
2016
Luigi Franchi, M.D., Ph.D.
Rationale design of immunotherapy for DIPG
Read More
2016
Robert Gatenby, M.D.
Combining targeted therapy and immunotherapy as an evolutionary double bind to optimize...
Read More